ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Latest Statistics Show Decline In Deaths From Breast Cancer

January 13, 1995

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

July 9, 2004

Pancreatic Cancer Treatment Shows Postive Early Results

December 30, 2005

2006 demonstration project to pay $23 per office visit.

November 4, 2005